Any thoughts on how this is going to look? Seems very strange when they already had 20 million + according to last 4c. I guess one benefit of current sp is they could raise 60 million and only issue 300 million shares which would be relatively small compared to the register size. I guess they now have a reasonable list of drugs with strong potential to make it to market? I'm assuming a capital raise is not another name for a takeover or buyout but I keep thinking the substantial holders surely would need a big buyer, not much chance of selling huge holding on market
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |